All India Institute Of Medical Sciences (aiims) has released a public tender for INJ AMPHOTERICIN B 50MG, INJ CASPOFUNGIN ACETATE 50MG INJ, INJ CASPOFUNGIN ACETATE 70 MG INJ, INJ CEFTAZIDIME 1GM INJ, INJ DICLOFENAC SODIUM 75MG Or 3ML, INJ ETOPHYLLINE 84. 7MG plus THEOPHYLLINE 25. 3MG, INJ IMIPENEM 1GM AND CILASTATIN IP 1 GM, INJ LEVOSULPRIDE 25MG, INJ METHYLPREDNISOLONE 1 GM, INJ METRONIDAZOLE 500MG or 100ML -100ML, INJ PHYTOMENADIONE 10MG or ML - 1ML, INJ RABIES VACCINE INJ 2. 5IU, INJ TERLIPRESSIN 1MG, INJ VALETHAMATE 8MG or ML, SODIUM PHOSPHATE ENEMA 100ML, INFUSION L- ORNITHINE L-ASPARTATE 500MG, SYRUP CETRIZINE 5MG or 5ML, HUMAN NORMAL IMMUNOGLOBULIN as per Specs, INJ AZTREONAM USP 1000MG, INJ COLISTIMETHATE SODIUM 3000000 3M IU, INJ POLYMYXIN B SULPHATE 500000 IU INJ, INJ TEICOPLANIN 400 MG, INJ TIGECYCLINE 50MG INJ, INJ CEFTAZIDIME 2GM INJ plus AVIBACTAM 0. 5GM in GORAKHPUR, UTTAR PRADESH. Quantity: 18673. Submission Deadline: 19-06-2025 11: 00: 00. Download documents and apply online.
Invitation to Bid – INJ AMPHOTERICIN B 50MG,INJ CASPOFUNGIN ACETATE 50MG INJ,INJ CASPOFUNGIN ACETATE 70 MG INJ,INJ CEFT in GORAKHPUR, UTTAR PRADESH
Posted
29 May 2025, 10:50 am
Deadline
19 Jun 2025, 11:00 am
EMD
₹32,000
Value
₹70,09,646
Location
Progress
RAQuantity
18673
Bid Type
Two Packet Bid
Categories
3
Bill of Quantities (BOQ)
24 Items
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | INJ AMPHOTERICIN B 50MG | Description1 | 437 | vial | [email protected] | 30 |
| 2 | INJ CASPOFUNGIN ACETATE 50MG INJ | Description2 | 36 | vial | [email protected] | 30 |
| 3 | INJ CASPOFUNGIN ACETATE 70 MG INJ | Description3 | 15 | vial | [email protected] | 30 |
| 4 | INJ CEFTAZIDIME 1GM INJ | Description4 | 225 | vial | [email protected] | 30 |
| 5 | INJ DICLOFENAC SODIUM 75MG Or 3ML | Description5 | 3,849 | ampoule | [email protected] | 30 |
| 6 | INJ ETOPHYLLINE 84.7MG plus THEOPHYLLINE 25.3MG | Description6 | 31 | ampoule | [email protected] | 30 |
| 7 | INJ IMIPENEM 1GM AND CILASTATIN IP 1 GM | Description7 | 514 | vial | [email protected] | 30 |
| 8 | INJ LEVOSULPRIDE 25MG | Description8 | 624 | ampoule | [email protected] | 30 |
| 9 | INJ METHYLPREDNISOLONE 1 GM | Description9 | 99 | vial | [email protected] | 30 |
| 10 | INJ METRONIDAZOLE 500MG or 100ML -100ML | Description10 | 7,367 | bottle | [email protected] | 30 |
| 11 | INJ PHYTOMENADIONE 10MG or ML - 1ML | Description11 | 349 | ampoule | [email protected] | 30 |
| 12 | INJ RABIES VACCINE INJ 2.5IU | Description12 | 600 | ampoule | [email protected] | 30 |
| 13 | INJ TERLIPRESSIN 1MG | Description13 | 90 | ampoule | [email protected] | 30 |
| 14 | INJ VALETHAMATE 8MG or ML | Description14 | 225 | ampoule | [email protected] | 30 |
| 15 | SODIUM PHOSPHATE ENEMA 100ML | Description15 | 547 | bottle | [email protected] | 30 |
| 16 | INFUSION L-ORNITHINE L-ASPARTATE 500MG | Description16 | 350 | ampoule | [email protected] | 30 |
| 17 | SYRUP CETRIZINE 5MG or 5ML | Description17 | 30 | bottle | [email protected] | 30 |
| 18 | HUMAN NORMAL IMMUNOGLOBULIN as per Specs | Description18 | 15 | vial | [email protected] | 30 |
| 19 | INJ AZTREONAM USP 1000MG | Description19 | 800 | vial | [email protected] | 30 |
| 20 | INJ COLISTIMETHATE SODIUM 3000000 3M IU | Description20 | 400 | vial | [email protected] | 30 |
| 21 | INJ POLYMYXIN B SULPHATE 500000 IU INJ | Description21 | 570 | vial | [email protected] | 30 |
| 22 | INJ TEICOPLANIN 400 MG | Description22 | 700 | vial | [email protected] | 30 |
| 23 | INJ TIGECYCLINE 50MG INJ | Description23 | 400 | vial | [email protected] | 30 |
| 24 | INJ CEFTAZIDIME 2GM INJ plus AVIBACTAM 0.5GM | Description24 | 400 | vial | [email protected] | 30 |
AI-Powered Bidder Prediction
Companies most likely to bid
Unlock Bidder Insights
AI predictions on likely bidders
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Reverse Auction Schedule
Start
22 Aug 2025, 03:00 pm
End
01 Oct 2025, 10:00 am
Duration: 955 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Frequently Asked Questions
What are the eligibility requirements for participating in tenders for PICU and RICU drugs?
The eligibility requirements include being a registered entity, possessing the requisite licenses for pharmaceutical distribution, and having prior experience in supplying medications to health departments. Bidders must also be compliant with relevant health regulations.
What certificates are required to submit with the tender?
Bidders must provide quality assurance certificates, product registration certificates, and compliance documents with Good Manufacturing Practices (GMP). These ensure that the medicines meet necessary health standards.
How can bidders register to participate in the tender?
Bidders need to register on the GEM portal and create a profile that includes all relevant business information. Once registered, they can access the tender document and submit proposals according to the guidelines laid down in the tender description.
What document formats are accepted for the tender submission?
Bidders should submit their proposals in PDF or Word format as specified in the tender documentation. It's crucial to follow the file naming conventions provided to avoid any issues during the evaluation process.
What technical specifications must be aligned with the tender requirements?
The technical specifications must include detailed descriptions of the product, its composition, efficacy data, and quality certifications. These documents help in assessing the suitability of the tender submission in meeting health and safety standards.
What are the payment terms and security requirements for this tender?
Successful bidders will be required to provide a Performance Security, which is a percentage of the bid value, to ensure contract compliance. Payments shall be made upon delivery and inspection of the goods against the contract requirements, following the acceptance of the products as per stipulated quality standards.
How will the evaluation and selection process be conducted?
The selection will be based on a thorough evaluation of the technical and financial proposals. Bids that meet the predetermined criteria for quality and pricing will be prioritized for contract awarding, ensuring an objective and transparent procurement process.
What benefits do MSEs and startups receive from this tender?
MSEs and startups can take advantage of relaxed eligibility criteria and additional support initiatives aimed at fostering local business participation. This is in line with promoting Make in India policies and enhancing local procurement initiatives.
What are the key timelines for submission and evaluation?
While specific dates are variable, bidders are advised to closely monitor the GEM portal for announcements regarding submission deadlines, evaluation timelines, and notifications of results post-evaluation. This ensures that all participants stay informed throughout the tender process.
Download FREE!
Access all tender documents at no cost
Documents 7
GeM-Bidding-7813258.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
Other Documents
OTHER
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
GeM-Bidding-7813258.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
Other Documents
OTHER
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS